prevalence of metabolic syndrome in tunisian overweight and obese children

##plugins.themes.academic_pro.article.sidebar##

Published Apr 19, 2019
Download
pdf
Vol. 97 No. 1 (2019): Issue Jan 2019

##plugins.themes.academic_pro.article.main##

Lobna Jmal
Aouatef Jmal
Monia Abdennebi
Moncef Feki
Samir Boukthir

Abstract

Aims : To assess the prevalence of metabolic syndrome (MS) and its parameters in a cohort of overweight and obese Tunisian schoolchildren and to investigate the involvement of leptin, and insulin in MS development via obesity.
Methods: A total of 306 schoolchildren between 10- 12 years: obese (n=35), overweight (n=99) and normal weight (n=172) were included in the study. Height, weight, waist circumference were measured and body mass index (BMI) was calculated. A blood sample was collected from each subject to measure glycemia, triglycerides, HDL cholesterol, leptin and insulin. MS diagnosis was based on criteria of  the International Diabetes Federation. Results: Prevalence of MS was 14.3% in obese children compared to 1% in overweight and 0% in controls (p0.001). Abdominal obesity and hypertension  were the most frequent parameters (88.6% and 25.7% respectively) in obese children. Leptin levels were significantly higher in children with MS (p0.001). In obese children, leptin was positively correlated to waist circumference (r=0.55; p=0.001) and insulin (r=0.52; p=0.002). After adjustment for BMI, leptin remained correlated with insulin (r=0.47; p0.001).
Conclusion: MS is relatively common among Tunisian overweight and obese children. Obesity is an important risk factor for MS development. Early management of childhood obesity is necessary to avoid metabolic complications.

Keywords:

Overweight, Obesity, Metabolic syndrome, Child, Leptin.

##plugins.themes.academic_pro.article.details##

References

  1. Speiser PW, Rudolf MC, Anhalt H et al. Consensus statement : childhood obesity. J Lin Endocrinol Metab 2005 ; 90 (3) : 1871-87.
  2. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017; 6(4): 397-407.
  3. Chen W, Srinivasan SR, Li S et al. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: The Bogalusa Heart Study. Diabetes Care 2005; 28 (1): 138-43.
  4. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
  5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37 (12): 1595-607.
  6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitusand its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
  7. Expert panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
  8. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366 (9491): 1059-62.
  9. Zimmet P, Alberti G, Kaufman F et al. The metabolic syndrome in children and adolescents. Lancet 2007; 369 (9579): 2059-61.
  10. Brambilla P, Pietrobelli A. Behind and beyond the pediatric metabolic syndrome. Ital J Pediatr 2009; 35:41.
  11. Boukthir S, Essadam L, Mazigh Mrad S et al. Prevalence and risk factors of overweight and obesity in elementary schoolchildren in the metropolitan region of Tunis, Tunisia. Tunis Med 2011; 89:50-54.
  12. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320:1240-3.
  13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: finding from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157:821-7.
  14. Abdennebi M, Ben Cheikh S, Bouaziz A et al. Prévalence du syndrome métabolique chez des enfants obèses tunisiens âgés de 6 à 12 ans. Obésité 2011; 6: 235-41.
  15. Matsha T, Hassan S, Bhata A et al. Metabolic syndrome in 10-16 year old learners from the western cape, south Africa: comparison of the NCEP ATP III and IDF criteria. Atherosclerosis 2009; 205:363-6.
  16. Mehairi AE, Khouri AA, Naqbi MM et al. Metabolic syndrome among Emirati Adolescents: A school based study. PLOS One 2013; 8: e56159.
  17. Zabarsky G , Beek C, Hagman E, Pierpont B, Caprio S, Weiss R. Impact of Severe Obesity on Cardiovascular Risk Factors in Youth. J Pediatr 2018;192:105-14.
  18. Jamoussi H, Mahjoub F, Sallemi H et al. Metabolic syndrome in Tunisian obese children and adolescents. Tunis Med 2012; 90 (1):36-40.
  19. Wang Q, Yin J, Xu L et al. Prevalence of metabolic syndrome in a cohort of a Chinese schoolchildren: comparison of two definitions and assessment of adipokines as components by factor analysis. BMC Public Health 2013; 13:249.
  20. Guijarro de Armas MA, Monerero Megias S, Merino Viveros M, Iglesias Bolanos P, Vega Pinero B. Prevalence of metabolic syndrome in a population of obese children and adolescents. Endocrinol Nutr 2012; 59:155-9.
  21. Lafortuna CL, Adorni F, Agosti F et al. Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract 2010; 88: 14-21.
  22. Sewaybricker LE, Antonio MA, Mendes RT, Barros Filho Ade A, Zambon MP. Metabolic syndrome in obese adolescents: what is enough? Rev Assoc Med Bras 2013; 59:64-71.
  23. Sangun O, Dundar B, Kosker M, Pirgon O, Dundar N. Prevalence of metabolic syndrome in obese children and adolescents using three different criteria and evaluation of risk factors. J Clin Pediatr Endocrinol 2011; 3: 70-6.
  24. Quah YV, Poh BK, Ismail MN. Metabolic syndrome based on IDF criteria in a sample of normal weight and obese school children. Malays J Nutr 2010;16:207-17.
  25. Lee S, Bacha F, Arslanian SA. Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr 2006; 149: 809-16.
  26. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001; 9:179-87.
  27. Freedman DS, Serdula MK, Srinivasan SR, Berenson GS. Relation of circumference and skinfold thickness to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart study. Am J Clin Nutr 1999; 69: 308-17.
  28. Savva SC, Tornaritis M, Savva ME et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 2000; 24: 1453-58.
  29. Mc Niece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007; 150 (6): 640-4.
  30. Sorof JM, Poffenbarger TS, Franco KD, Bernard L, Portman RJ. Isolated systolic hypertension, obesity and hyperkinetic hemodynamic states in children. J Pediatr 2002; 140: 660-6.
  31. Mameli C, Krakauer NY, Krakauer JC, Bosetti A, Ferrari CM, Moiana N, et al. (2018) The association between a body shape index and cardiovascular risk in overweight and obese children and adolescents. PLoS ONE 13(1):e0190426.
  32. Pedrosa C, Oliveira BM, Albuquerque I et al. Obesity and metabolic syndrome in 7-9 years-old Potuguese schoolchildren. Diabetol Metab Syndr 2010; 2: 40.
  33. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up? J Pediatr 2008; 152:160-4.
  34. Steinberger J, Steffen L, Jacobs DR et al. Relation of leptin to insulin resistance syndrome in children. Obes Res 2003; 11:1124-30.
  35. Chu NF, Chang JB, Shieh SM. Plama lepin, fatty acids and tumor necrosis factor-receptor and insulin resistance in children. Obes Res 2003 11:532-40.
  36. Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels : its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab 1996 ; 81(12) : 4433-8.
  37. Schwartz MW, Prigeon RL, Kahn SE et al. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 1997 ; 20(9) : 1776-81.
  38. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20 : plasma leptin, obesity, and plasma insulin in type 2 diabetes subjects. J Clin Endocrinol Metab 1997 ; 82 (2) : 579-84.
  39. Ding W, Cheng H, Chen F, Yan Y, Zhang M, Zhao X, HouD, Mi J. Adipokines are Associated With Hypertension in Metabolically Healthy Obese (MHO) Children and Adolescents:A Prospective Population-Based Cohort Study. J Epidemiol 2018;28(1):19-26